Acea Biosciences
Agilent to Acquire BioTek Instruments for $1.17B
Vermont-based BioTek is a privately held company that manufactures and sells life science instruments, including cell imaging systems.
Agilent to Acquire ACEA Biosciences
ACEA's xCELLigence impedance-based, label-free, real-time cell analysis instruments are used in immuno-oncology pre-clinical drug discovery and development.
IP Roundup: Jan 25, 2011
Premium
Yale University, University of South Florida, Alabama State University, Stanford University, SRU Biosystems, Eppendorf Array Technology, Agilent Technologies, Acea Biosciences
Acea, Vivo Biosciences Partner to Develop Assays for Roche's xCelligence System
The new label-free and real-time cell-based assays will incorporate Vivo's HuBiogel platform.
Cellular Dynamics, Roche, Acea Partner on Cardiotoxic Prediction Research
The firms are developing a system for the early and accurate prediction of cardiotoxic side effects in the drug discovery process.